Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01155414 · ClinicalTrials.gov registry record · Phase 3
Tolerance of Healthy Term Infants Fed Infant Formulas #4
A Phase 3 study, sponsored by Abbott Nutrition.
- Completed
- Registry status
- Phase 3
- Development phase
- 168
- Enrollment target
NCT01155414 is a Phase 3 study that has completed, run by Abbott Nutrition. The registered enrollment target is 168 participants.
The verdict
NCT01155414, a Phase 3 study, has completed, sponsored by Abbott Nutrition.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 168 participants
- Enrollment target
Study Summary
The primary objective of this study is to assess the comparative gastrointestinal (GI) tolerance of normal term infants to two experimental powdered formulas compared with a commercially available powdered formula.
Interventions
- OTHER Hydrolysate based infant formula
- OTHER Investigational Infant Formula A
- OTHER Investigational Infant Formula B
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2010-03 |
| Est. Completion | 2010-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01155414
The ClinicalTrials.gov registry entry for NCT01155414 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Nutrition, which has 89 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Hydrolysate based infant formula is the first listed.
NCT01155414 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01155414 about?
NCT01155414 is a clinical study titled "Tolerance of Healthy Term Infants Fed Infant Formulas #4". The primary objective of this study is to assess the comparative gastrointestinal (GI) tolerance of normal term infants to two experimental powdered formulas compared with a commercially available powdered formula.
What is the current status of trial NCT01155414?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 168 participants. The study started on 2010-03. Estimated completion is 2010-07.
What interventions are being tested in trial NCT01155414?
The interventions under investigation include: Hydrolysate based infant formula (OTHER), Investigational Infant Formula A (OTHER), Investigational Infant Formula B (OTHER).
Who is sponsoring clinical trial NCT01155414?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.